Paidion Research, Inc   Report issue

For profit Phase 3
Founded: Durham NC United States (2013)
Status: Acquired by Camargo Pharmaceutical Services (2021) → now Premier Research Group (2021)

Organization Overview

First Clinical Trial
2017
NCT03186378
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Paidion Research, Inc.